Covid 19

Jubilant Life Sciences Limited : pro-active, multi-pronged measures to curb the spread of novel Coronavirus (COVID-19)

Given the recent threat by the novel Coronavirus (COVID-19), Jubilant Life Sciences Limited has taken several proactive measures to curb the spread of the contagious virus among its employees and stakeholders. A company-wide awareness campaign was launched with informative emailers. Internal travel advisories have been issued to all employees and all international and domestic travel…

Venom Immunotherapy Supplies

Venom Immunotherapy Supply Update

One year ago, we announced that our company had become the sole provider of venom immunotherapy products in the U.S.—a position brought about by the departure from the market of the only other supplier. In the ensuing year, we have committed all of our resources to ensuring a long-term, consistent supply of venom products for our customers. We’re pleased to share with you this brief overview of what we’ve been working on, and advances CMS has made with reimbursements.

BeeAware Allergy Relaunches

New Year • New Program For nearly a decade, HollisterStier Allergy’s BeeAware program has helped educate patients and physicians about venom immunotherapy. We are excited to announce the roll-out of our refreshed BeeAware program and the launch of a fresh and updated website. Patient education delivered in a new and improved package The BeeAware program…

Venom Immunotherapy Supplies

Venom Immunotherapy Supplies

Read as letter Read related AAAAI/ACAAI email to members At the end of February 2018, we learned that we will be the only supplier of venom immunotherapy products in North America. In light of this situation, we have evaluated our production capabilities as they relate to our ability to indefinitely supply the entire North American…

Man’s best friend

Man’s best friend

It may be AP Dog if he’s allergic to his canine companion. According to the U.S. Pet Ownership & Demographics Sourcebook (2012), there is at least one dog living in over 36 percent of US households. That translates to 43,346,000 homes with at least one dog in residence. While only 10 percent1 of people are allergic to them,…

Chris Preti

Chris Preti Joins Company as President

January 22, 2018 – Jubilant Pharma announces the appointment of Chris Preti to the position of President for its allergy company, HollisterStier Allergy. Mr. Preti has over 25 years of progressive pharmaceutical experience. He began his career at GlaxoSmithKline in research and development, developing products for regulatory submission across multiple therapeutic areas. He then joined…